High-flow nasal cannula (HFNC) oxygenation for sclerotherapy of facial and upper airway vascular malformations in pediatric patients: Case series.
| Autor: | Zadkar S; Department of Anaesthesiology and Critical Care, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India., Ranjitha YS; Anaesthesiology and Critical Care, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India., Mishra P; Department of Anaesthesiology and Critical Care, Jaslok Hospital, Mumbai, Maharashtra, India., Saraf R; Interventional Neuroradiology, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of anaesthesiology, clinical pharmacology [J Anaesthesiol Clin Pharmacol] 2023 Apr-Jun; Vol. 39 (2), pp. 309-312. Date of Electronic Publication: 2022 May 13. |
| DOI: | 10.4103/joacp.joacp_238_21 |
| Abstrakt: | We report anesthesia management of sclerotherapy for vascular malformations (VMs) of the upper airway and face of pediatric patients conducted under sedation using a high-flow nasal cannula (HFNC) oxygen delivery system. Sclerotherapy procedures were carried out in six patients (five males, one female; age group: 5-12 years). The patients were sedated with midazolam, fentanyl, ketamine, and graded doses of propofol along with continuous oxygen delivery using HFNC. There were no episodes of oxygen desaturation, tongue fall or obstruction of the airway, interruption of procedure for assisted ventilation, and postoperative nausea and vomiting (PONV). Only two patients showed transient apnea for 10 and 15 s but did not require ventilatory assistance. HFNC provides effective oxygenation in pediatric patients undergoing sclerotherapy of VMs of the upper airway and face under sedation. Competing Interests: There are no conflicts of interest. (Copyright: © 2022 Journal of Anaesthesiology Clinical Pharmacology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|